Chinese General Practice ›› 2023, Vol. 26 ›› Issue (05): 591-597.DOI: 10.12114/j.issn.1007-9572.2022.0556
Special Issue: 营养最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2022-05-29
Revised:
2022-09-18
Published:
2023-02-15
Online:
2022-09-29
Contact:
HE Yuqing
通讯作者:
何玉清
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0556
年份(年) | APC(95%CI)(%) | AAPC(95%CI)(%) |
---|---|---|
1990—1995 | -1.3(-1.9,-0.7)a | 0.7(0.3,1.1)a |
1995—2006 | 0.9(0.7,1.1)a | |
2006—2010 | 2.5(1.1,3.9)a | |
2010—2014 | -2.3(-3.6,-1.0)a | |
2014—2017 | 0.2(-2.4,2.9) | |
2017—2019 | 8.9(6.0,11.9)a |
Table 1 Joinpoint analysis of trends in standardized incidence ratio of protein-energy malnutrition in China from 1990 to 2019
年份(年) | APC(95%CI)(%) | AAPC(95%CI)(%) |
---|---|---|
1990—1995 | -1.3(-1.9,-0.7)a | 0.7(0.3,1.1)a |
1995—2006 | 0.9(0.7,1.1)a | |
2006—2010 | 2.5(1.1,3.9)a | |
2010—2014 | -2.3(-3.6,-1.0)a | |
2014—2017 | 0.2(-2.4,2.9) | |
2017—2019 | 8.9(6.0,11.9)a |
年龄(岁) | 年份(年) | APC(95%CI)(%) | AAPC(95%CI)(%) | 年龄(岁) | 年份(年) | APC(95%CI)(%) | AAPC(95%CI)(%) |
---|---|---|---|---|---|---|---|
<5 | 1990—1994 | -7.2(-9.1,-5.2)a | -2.1(-2.5,-1.7)a | 45~49 | 1990—2000 | 2.4(2.3,2.6)a | 2.1(1.8,2.5)a |
1994—2003 | -2.3(-3.0,-1.6)a | 2000—2005 | 1.2(0.5,1.9)a | ||||
2003—2019 | -0.7(-0.9,-0.4)a | 2005—2010 | 3.4(2.7,4.2)a | ||||
5~9 | 1990—1995 | 1.7(1.4,2.0)a | 2.3(2.1,2.5)a | 2010—2014 | -0.9(-2.0,0.3) | ||
1995—2001 | 4.9(4.6,5.3)a | 2014—2017 | 1.0(-1.3,3.4) | ||||
2001—2010 | 2.8(2.6,3.0)a | 2017—2019 | 7.4(5.0,9.9)a | ||||
2010—2014 | -6.0(-6.6,-5.3)a | 50~54 | 1990—2001 | 2.2(2.0,2.3)a | 2.0(1.6,2.3)a | ||
2014—2017 | -1.0(2.4,0.4) | 2001—2005 | 0.6(-0.4,1.7) | ||||
2017—2019 | 17.3(15.7,19.0)a | 2005—2010 | 3.6(2.9,4.3)a | ||||
10~14 | 1990—1995 | 1.8(1.6,2.0)a | 2.3(2.1,2.4)a | 2010—2014 | -0.6(-1.6,0.5) | ||
1995—2000 | 4.4(4.1,4.7)a | 2014—2017 | 1.0(-1.2,3.1) | ||||
2000—2010 | 3.0(3.0,3.1)a | 2017—2019 | 6.3(4.0,8.5)a | ||||
2010—2014 | -5.2(-5.6,-4.7)a | 55~59 | 1990—2000 | 2.2(2.1,2.3)a | 1.9(1.7,2.1)a | ||
2014—2017 | -0.6(-1.6,0.4) | 2000—2005 | 0.6(0.1,1.1)a | ||||
2017—2019 | 15.1(14.0,16.3)a | 2005—2010 | 3.5(3.0,4.0)a | ||||
15~19 | 1990—1995 | 1.8(1.4,2.3)a | 2.2(1.9,2.6)a | 2010—2014 | -0.2(-0.9,0.5) | ||
1995—1999 | 4.2(3.2,5.2)a | 2014—2017 | 1.0(-0.5,2.4) | ||||
1999—2010 | 2.8(2.7,3.0)a | 2017—2019 | 5.8(4.3,7.4)a | ||||
2010—2014 | -3.5(-4.5,-2.6)a | 60~64 | 1990—2000 | 2.2(2.1,2.4)a | 1.9(1.7,2.1)a | ||
2014—2017 | -0.6(-2.5,1.4) | 2000—2005 | 0.3(-0.1,0.8) | ||||
2017—2019 | 13.0(10.8,15.2)a | 2005—2010 | 3.5(3.0,4.0)a | ||||
20~24 | 1990—1995 | 2.0(1.6,2.3)a | 2.3(2.1,2.5)a | 2010—2014 | -0.2(-0.9,0.6) | ||
1995—1999 | 4.0(3.2,4.8)a | 2014—2017 | 1.0(-0.4,2.5) | ||||
1999—2010 | 2.5(2.4,2.7)a | 2017—2019 | 5.5(4.0,7.0)a | ||||
2010—2014 | -2.6(-3.3,-1.9)a | 65~69 | 1990—2000 | 2.2(2.1,2.3)a | 1.8(1.7,2.0)a | ||
2014—2017 | 0.4(-1.0,1.9) | 2000—2005 | 0.4(0.1,0.7)a | ||||
2017—2019 | 11.6(9.9,13.3)a | 2005—2010 | 3.5(3.2,3.8)a | ||||
25~29 | 1990—1995 | 1.9(1.2,2.5)a | 2.2(1.8,2.7)a | 2010—2014 | 0(-0.5,0.5) | ||
1995—1998 | 4.1(1.2,7.0)a | 2014—2017 | 1.0(0,2.0) | ||||
1998—2010 | 2.6(2.4,2.8)a | 2017—2019 | 4.5(3.5,5.5)a | ||||
2010—2014 | -2.4(-3.8,-1.1)a | 70~74 | 1990—2000 | 2.2(2.1,2.3)a | 1.8(1.7,2.0)a | ||
2014—2017 | 0.4(-2.3,3.3) | 2000—2005 | 0.3(-0.1,0.7) | ||||
2017—2019 | 11.1(8.0,14.2)a | 2005—2010 | 3.7(3.4,4.1)a | ||||
30~34 | 1990—1995 | 1.8(1.3,2.2)a | 2.1(1.9,2.4)a | 2010—2017 | 0.4(0.2,0.6)a | ||
1995—1999 | 3.6(2.5,4.7)a | 2017—2019 | 4.5(3.3,5.8)a | ||||
1999—2005 | 2.0(1.5,2.4)a | 75~79 | 1990—2000 | 2.0(1.9,2.0)a | 1.8(1.8,1.9)a | ||
2005—2010 | 3.0(2.3,3.7)a | 2000—2005 | 0.3(0,0.5)a | ||||
2010—2017 | -1.1(-1.5,-0.8)a | 2005—2010 | 3.8(3.6,4.1)a | ||||
2017—2019 | 10.1(7.8,12.5)a | 2010—2017 | 0.8(0.7,0.9)a | ||||
35~39 | 1990—2001 | 2.6(2.4,2.7)a | 2.2(1.8,2.6)a | 2017—2019 | 3.8(3.1,4.6)a | ||
2001—2005 | 1.3(0.1,2.5)a | 80~84 | 1990—2000 | 1.9(1.9,2.0)a | 1.8(1.8,1.9)a | ||
2005—2010 | 3.6(2.8,4.4)a | 2000—2005 | 0.2(0.1,0.3)a | ||||
2010—2014 | -1.5(-2.6,-0.3)a | 2005—2010 | 4.0(3.8,4.1)a | ||||
2014—2017 | 0.8(-1.5,3.2) | 2010—2017 | 1.0(0.9,1.1)a | ||||
2017—2019 | 8.3(5.8,10.8)a | 2017—2019 | 4.0(3.4,4.5)a | ||||
40~44 | 1990—1995 | 1.9(1.6,2.2)a | 2.1(1.9,2.3)a | ≥85 | 1990—2000 | 1.5(1.4,1.5)a | 1.6(1.5,1.6)a |
1995—1999 | 3.5(2.8,4.2)a | 2000—2005 | -0.3(-0.5,-0.1)a | ||||
1999—2005 | 1.3(0.9,1.6)a | 2005—2010 | 3.8(3.6,4.0)a | ||||
2005—2010 | 3.3(2.8,3.7)a | 2010—2016 | 0.3(0.2,0.5)a | ||||
2010—2016 | -0.7(-1.0,-0.4)a | 2016—2019 | 3.7(3.4,4.0)a | ||||
2016—2019 | 5.9(5.2,6.7)a |
Table 2 Joinpoint regression analysis of the trend of age-specific incidence of protein-energy malnutrition in China from 1990 to 2019
年龄(岁) | 年份(年) | APC(95%CI)(%) | AAPC(95%CI)(%) | 年龄(岁) | 年份(年) | APC(95%CI)(%) | AAPC(95%CI)(%) |
---|---|---|---|---|---|---|---|
<5 | 1990—1994 | -7.2(-9.1,-5.2)a | -2.1(-2.5,-1.7)a | 45~49 | 1990—2000 | 2.4(2.3,2.6)a | 2.1(1.8,2.5)a |
1994—2003 | -2.3(-3.0,-1.6)a | 2000—2005 | 1.2(0.5,1.9)a | ||||
2003—2019 | -0.7(-0.9,-0.4)a | 2005—2010 | 3.4(2.7,4.2)a | ||||
5~9 | 1990—1995 | 1.7(1.4,2.0)a | 2.3(2.1,2.5)a | 2010—2014 | -0.9(-2.0,0.3) | ||
1995—2001 | 4.9(4.6,5.3)a | 2014—2017 | 1.0(-1.3,3.4) | ||||
2001—2010 | 2.8(2.6,3.0)a | 2017—2019 | 7.4(5.0,9.9)a | ||||
2010—2014 | -6.0(-6.6,-5.3)a | 50~54 | 1990—2001 | 2.2(2.0,2.3)a | 2.0(1.6,2.3)a | ||
2014—2017 | -1.0(2.4,0.4) | 2001—2005 | 0.6(-0.4,1.7) | ||||
2017—2019 | 17.3(15.7,19.0)a | 2005—2010 | 3.6(2.9,4.3)a | ||||
10~14 | 1990—1995 | 1.8(1.6,2.0)a | 2.3(2.1,2.4)a | 2010—2014 | -0.6(-1.6,0.5) | ||
1995—2000 | 4.4(4.1,4.7)a | 2014—2017 | 1.0(-1.2,3.1) | ||||
2000—2010 | 3.0(3.0,3.1)a | 2017—2019 | 6.3(4.0,8.5)a | ||||
2010—2014 | -5.2(-5.6,-4.7)a | 55~59 | 1990—2000 | 2.2(2.1,2.3)a | 1.9(1.7,2.1)a | ||
2014—2017 | -0.6(-1.6,0.4) | 2000—2005 | 0.6(0.1,1.1)a | ||||
2017—2019 | 15.1(14.0,16.3)a | 2005—2010 | 3.5(3.0,4.0)a | ||||
15~19 | 1990—1995 | 1.8(1.4,2.3)a | 2.2(1.9,2.6)a | 2010—2014 | -0.2(-0.9,0.5) | ||
1995—1999 | 4.2(3.2,5.2)a | 2014—2017 | 1.0(-0.5,2.4) | ||||
1999—2010 | 2.8(2.7,3.0)a | 2017—2019 | 5.8(4.3,7.4)a | ||||
2010—2014 | -3.5(-4.5,-2.6)a | 60~64 | 1990—2000 | 2.2(2.1,2.4)a | 1.9(1.7,2.1)a | ||
2014—2017 | -0.6(-2.5,1.4) | 2000—2005 | 0.3(-0.1,0.8) | ||||
2017—2019 | 13.0(10.8,15.2)a | 2005—2010 | 3.5(3.0,4.0)a | ||||
20~24 | 1990—1995 | 2.0(1.6,2.3)a | 2.3(2.1,2.5)a | 2010—2014 | -0.2(-0.9,0.6) | ||
1995—1999 | 4.0(3.2,4.8)a | 2014—2017 | 1.0(-0.4,2.5) | ||||
1999—2010 | 2.5(2.4,2.7)a | 2017—2019 | 5.5(4.0,7.0)a | ||||
2010—2014 | -2.6(-3.3,-1.9)a | 65~69 | 1990—2000 | 2.2(2.1,2.3)a | 1.8(1.7,2.0)a | ||
2014—2017 | 0.4(-1.0,1.9) | 2000—2005 | 0.4(0.1,0.7)a | ||||
2017—2019 | 11.6(9.9,13.3)a | 2005—2010 | 3.5(3.2,3.8)a | ||||
25~29 | 1990—1995 | 1.9(1.2,2.5)a | 2.2(1.8,2.7)a | 2010—2014 | 0(-0.5,0.5) | ||
1995—1998 | 4.1(1.2,7.0)a | 2014—2017 | 1.0(0,2.0) | ||||
1998—2010 | 2.6(2.4,2.8)a | 2017—2019 | 4.5(3.5,5.5)a | ||||
2010—2014 | -2.4(-3.8,-1.1)a | 70~74 | 1990—2000 | 2.2(2.1,2.3)a | 1.8(1.7,2.0)a | ||
2014—2017 | 0.4(-2.3,3.3) | 2000—2005 | 0.3(-0.1,0.7) | ||||
2017—2019 | 11.1(8.0,14.2)a | 2005—2010 | 3.7(3.4,4.1)a | ||||
30~34 | 1990—1995 | 1.8(1.3,2.2)a | 2.1(1.9,2.4)a | 2010—2017 | 0.4(0.2,0.6)a | ||
1995—1999 | 3.6(2.5,4.7)a | 2017—2019 | 4.5(3.3,5.8)a | ||||
1999—2005 | 2.0(1.5,2.4)a | 75~79 | 1990—2000 | 2.0(1.9,2.0)a | 1.8(1.8,1.9)a | ||
2005—2010 | 3.0(2.3,3.7)a | 2000—2005 | 0.3(0,0.5)a | ||||
2010—2017 | -1.1(-1.5,-0.8)a | 2005—2010 | 3.8(3.6,4.1)a | ||||
2017—2019 | 10.1(7.8,12.5)a | 2010—2017 | 0.8(0.7,0.9)a | ||||
35~39 | 1990—2001 | 2.6(2.4,2.7)a | 2.2(1.8,2.6)a | 2017—2019 | 3.8(3.1,4.6)a | ||
2001—2005 | 1.3(0.1,2.5)a | 80~84 | 1990—2000 | 1.9(1.9,2.0)a | 1.8(1.8,1.9)a | ||
2005—2010 | 3.6(2.8,4.4)a | 2000—2005 | 0.2(0.1,0.3)a | ||||
2010—2014 | -1.5(-2.6,-0.3)a | 2005—2010 | 4.0(3.8,4.1)a | ||||
2014—2017 | 0.8(-1.5,3.2) | 2010—2017 | 1.0(0.9,1.1)a | ||||
2017—2019 | 8.3(5.8,10.8)a | 2017—2019 | 4.0(3.4,4.5)a | ||||
40~44 | 1990—1995 | 1.9(1.6,2.2)a | 2.1(1.9,2.3)a | ≥85 | 1990—2000 | 1.5(1.4,1.5)a | 1.6(1.5,1.6)a |
1995—1999 | 3.5(2.8,4.2)a | 2000—2005 | -0.3(-0.5,-0.1)a | ||||
1999—2005 | 1.3(0.9,1.6)a | 2005—2010 | 3.8(3.6,4.0)a | ||||
2005—2010 | 3.3(2.8,3.7)a | 2010—2016 | 0.3(0.2,0.5)a | ||||
2010—2016 | -0.7(-1.0,-0.4)a | 2016—2019 | 3.7(3.4,4.0)a | ||||
2016—2019 | 5.9(5.2,6.7)a |
年份(年) | 预测值(1/10万) | 95%CI |
---|---|---|
2020 | 2 280.32 | (2 241.77,2 280.32) |
2021 | 2 637.44 | (2 519.85,2 755.03) |
2022 | 3 059.19 | (2 815.37,3 303.02) |
2023 | 3 537.93 | (3 117.49,3 958.36) |
2024 | 4 066.89 | (3 417.65,4 716.14) |
2025 | 4 640.15 | (3 709.01,5 571.29) |
2025 | 5 252.45 | (3 986.07,6 518.83) |
2027 | 5 899.17 | (4 244.42,7 553.91) |
2028 | 6 576.23 | (4 480.54,8 671.92) |
2029 | 7 280.06 | (4 691.61,9 868.50) |
Table 3 The standardized incidence ratio of protein-energy malnutrition in China from 2020-2029 predicted using ARIMA(1,2,0) model
年份(年) | 预测值(1/10万) | 95%CI |
---|---|---|
2020 | 2 280.32 | (2 241.77,2 280.32) |
2021 | 2 637.44 | (2 519.85,2 755.03) |
2022 | 3 059.19 | (2 815.37,3 303.02) |
2023 | 3 537.93 | (3 117.49,3 958.36) |
2024 | 4 066.89 | (3 417.65,4 716.14) |
2025 | 4 640.15 | (3 709.01,5 571.29) |
2025 | 5 252.45 | (3 986.07,6 518.83) |
2027 | 5 899.17 | (4 244.42,7 553.91) |
2028 | 6 576.23 | (4 480.54,8 671.92) |
2029 | 7 280.06 | (4 691.61,9 868.50) |
[1] |
|
[2] |
|
[3] |
GBD Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1204-1222. DOI:10.1016/S0140-6736(20)30925-9.
|
[4] |
肖瑛,钟晨晖,魏凤华,等. 2004—2018年湖北省人群血吸虫病流行趋势Joinpoint回归分析[J]. 中国血吸虫病防治杂志,2022,34(2):122-127. DOI:10.16250/j.32.1374.2022011.
|
[5] |
高慧,陈馨馨,姜玉,等. 2010—2017年基于Joinpoint回归模型上海长宁区中小学生伤害趋势分析[J]. 公共卫生与预防医学,2021,32(5):24-27. DOI:10.3969/j.issn.1006-2483.2021.05.006.
|
[6] |
李志超,刘升. 基于ARIMA模型、灰色模型和回归模型的预测比较[J]. 统计与决策,2019,35(23):38-41. DOI:10.13546/j.cnki.tjyjc.2019.23.007.
|
[7] |
徐杰茹,陈磊,王冕,等. 1990—2019年中国女性卵巢癌发病趋势分析与预测[J]. 现代预防医学,2021,48(19):3457-3460,3470.
|
[8] |
赵创艺,袁空军,杨媛,等. 基于ARIMA与NNAR模型的中国慢性阻塞性肺疾病疾病负担预测研究[J]. 中国全科医学,2022,25(16):1942-1949. DOI:10.12114/j.issn.1007-9572.2022.0045.
|
[9] |
岳雅琪,沈娟,顾雅芳,等. 上海某社区0~24月龄婴幼儿营养不良现况分析[J]. 社区医学杂志,2018,16(18):1382-1384,1388.
|
[10] |
张芳霞,胡颖,宋亚楠,等. 遵义地区1岁以下农村留守儿童蛋白质-能量营养不良状况调查及影响因素分析[J]. 中国全科医学,2021,24(11):1406-1409. DOI:10.12114/j.issn.1007-9572.2021.00.137.
|
[11] |
范建桢,魏红,汪亚文,等. 成年维持性血液透析病人蛋白质-能量消耗研究进展[J]. 护理研究,2019,33(2):302-305. DOI:10.12102/j.issn.1009-6493.2019.02.028.
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[1] | WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846. |
[2] | LONG Chunxiao, LI Chenglu, FAN Yangdong, SHI Lei. Quantitative Analysis of Chronic Disease Prevention and Treatment Policy Texts in China: Three-dimensional Framework Based on Policy Tools, Policy Evolution and Policy Subjects [J]. Chinese General Practice, 2025, 28(20): 2457-2463. |
[3] | FANG Yingying, LIN Weiquan, SUN Minying, LI Yaohui, LIU Lan, YANG Yunou, CHEN Jiamin, LUO Liying, SHI Lei, LIU Hui. Influence of Screen Time on Sleep Quality among Patients with Multimorbidity Aged 35 and Above [J]. Chinese General Practice, 2025, 28(20): 2501-2507. |
[4] | GUO Yi, HAN Xuanye, LIU Zhaojun, JIANG Yaoyao, FU Yang, SHI Lei, ZHAO Shihong. Construction of a Medical Transition Intervention Model for Multiple Chronic Diseases in Children Based on the E-Coach Management Model [J]. Chinese General Practice, 2025, 28(20): 2530-2537. |
[5] | PAN Yaojia, FU Fanglin, HAN Zheng, SUN Meng, GU Huaicong, WANG Weiqiang. Correlation of the Type of Obesity with the Cardiometabolic Multimorbidity: a Study in Male and Female Middle-aged Residents in Anhui Province [J]. Chinese General Practice, 2025, 28(18): 2285-2293. |
[6] | CHEN Qiaoqiao, SU Ping, ZHAO Yingying, PANG Jinhong, SHI Jie, WANG Yaqian, LI Qiuchun, HE Ruiyan, WANG Yue, CHEN Xueyu, QIAO Junpeng, CHI Weiwei. Association between Triglyceride-Glucose Index and Incident Cardiometabolic Multimorbidity in the Elderly: a Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(18): 2270-2277. |
[7] | ZHANG Zhidong, JIN Hua, HU Jihong, JIANG Lu, WANG Li, LONG Kaichong, ZHANG Ronghua. Analysis and Prediction of the Incidence and Mortality Trends of Hypertensive Nephropathy in China from 1990 to 2021 [J]. Chinese General Practice, 2025, 28(18): 2262-2269. |
[8] | HAN Zheng, SUN Meng, FU Fanglin, PAN Yaojia, WANG Weiqiang. A Study on the Relationship between the Triglyceride-Glucose Index and Cardiometabolic Multimorbidity in Individuals Aged 50 and Above [J]. Chinese General Practice, 2025, 28(18): 2278-2284. |
[9] | FANG Liangmei, MIAO Ruifen, WANG Rong, QIU Beibei, HONG Xin, WANG Lina. Analysis of Changing Trends in Disease Burden of Multidrug-resistant Tuberculosis in China, 1992-2021 [J]. Chinese General Practice, 2025, 28(17): 2163-2171. |
[10] | CHENG Zhuozhuo, ZHANG Rui, XU Haofeng, HUANG Junting, LIANG Zijing, YAN Ping. Systematic Cluster Analysis of Comorbidity Patterns in Patients with Chronic Obstructive Pulmonary Disease and the Impact on Hospitalization Costs [J]. Chinese General Practice, 2025, 28(17): 2127-2133. |
[11] | ZHAO Can, SHEN Ying, XI Qian, PENG Houxuan, QIN Jinqiong, WANG Xuan, ZHENG Yanping, QIN Li, ZUO Yanli. The Hospitalization Spending and Associated Factors in Inpatients with Multimorbidity in Township Health Centers in Guangxi [J]. Chinese General Practice, 2025, 28(16): 2039-2049. |
[12] | CAO Chenchen, ZHENG Lyuyun, WANG Lin, LIU Jing. Preference Study on Family Doctor Contract Service among Patients with Hypertension and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(16): 2011-2016. |
[13] | LI Xin, LUO Sha, WANG Hongping, XU Hanqing. Research on the Burden of Migraine among Chinese Young People Aged 10-24 from 1990 to 2021 [J]. Chinese General Practice, 2025, 28(15): 1923-1931. |
[14] | GE Qiong, HU Jiakang, YU Yuqi, LAI Wenwen, LUO Shiwen, LU Quqin. Bibliometric Analysis of RNA-seq Technology in Liver Cancer Research [J]. Chinese General Practice, 2025, 28(12): 1473-1478. |
[15] | Chinese Academy Society of Sleep Medicine, Chinese Medical Doctor Association, Sleep Medicine Group, China Neurologist Association. Chinese Guideline for Diagnosis and Treatment of Co-morbid Insomnia and Obstructive Sleep Apnea (2024) [J]. Chinese General Practice, 2025, 28(11): 1289-1303. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||